Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-4-13
pubmed:abstractText
Abdominal aortic aneurysms (AAAs) are associated with chronic inflammation, disruption of medial elastin, and increased local production of elastolytic matrix metalloproteinases (MMPs). The purpose of this study was to investigate how treatment with a hydroxamate-based MMP antagonist (RS 132908) might affect the development of experimental AAAs.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0741-5214
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
522-32
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:10069917-Animals, pubmed-meshheading:10069917-Aorta, Abdominal, pubmed-meshheading:10069917-Aortic Aneurysm, Abdominal, pubmed-meshheading:10069917-Collagen, pubmed-meshheading:10069917-Desmosine, pubmed-meshheading:10069917-Disease Models, Animal, pubmed-meshheading:10069917-Elastin, pubmed-meshheading:10069917-Hydroxamic Acids, pubmed-meshheading:10069917-Hydroxyproline, pubmed-meshheading:10069917-Injections, Intra-Arterial, pubmed-meshheading:10069917-Injections, Subcutaneous, pubmed-meshheading:10069917-Male, pubmed-meshheading:10069917-Metalloendopeptidases, pubmed-meshheading:10069917-Pancreatic Elastase, pubmed-meshheading:10069917-Pharmaceutical Vehicles, pubmed-meshheading:10069917-Protease Inhibitors, pubmed-meshheading:10069917-Rats, pubmed-meshheading:10069917-Rats, Wistar
pubmed:year
1999
pubmed:articleTitle
Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908).
pubmed:affiliation
Department of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't